The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
Open accessAbstract
BACKGROUND: Restricting protein intake and controlling hypertension delay the progression of renal disease in animals. We tested these interventions in 840 patients with various chronic renal diseases. METHODS: In study 1, 585 patients with glomerular filtration rates of 25 to 55 ml per minute per 1.73 m2 of body-surface area were randomly assigned to a usual-protein diet or a low-protein diet (1.3 or 0.58 g of protein per kilogram of body weight per day) and to a usual- or a low-blood-pressure group (mean arterial pressure, 107 or 92 mm Hg). In study 2, 255 patients with glomerular filtration rates of 13 to 24 ml per minute per 1.73 m2 were randomly assigned to the low-protein diet (0.58 g per kilogram per day) or a very-low-protein diet (0.28 g per kilogram per day) with a keto acid-amino acid supplement, and a usual- or a low-blood-pressure group (same values as those in study 1). An 18-to-45-month follow-up was planned, with monthly evaluations of the patients. RESULTS: The mean follow-up was 2.2 years. In study 1, the projected mean decline in the glomerular filtration rate at three years did not differ significantly between the diet groups or between the blood-pressure groups. As compared with the usual-protein group and the usual-blood-pressure group, the low-protein group and the low-blood-pressure group had a more rapid decline in the glomerular filtration rate during the first four months after randomization and a slower decline thereafter. In study 2, the very-low-protein group had a marginally slower decline in the glomerular filtration rate than did the low-protein group (P = 0.07). There was no delay in the time to the occurrence of end-stage renal disease or death. In both studies, patients in the low-blood-pressure group who had more pronounced proteinuria at base line had a significantly slower rate of decline in the glomerular filtration rate. CONCLUSIONS: Among patients with moderate renal insufficiency, the slower decline in renal function that started four months after the introduction of a low-protein diet suggests a small benefit of this dietary intervention. Among patients with more severe renal insufficiency, a very-low-protein diet, as compared with a low-protein diet, did not significantly slow the progression of renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with a noneproteinlimited diet, a low-protein diet of 0.6 g/kg BW/d can prevent a decline in GFR of approximately 1 mL/min per year per 1.73 m 2 and is associated with a 30% decrease in reaching a dialysisdependent stage.114,115”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reducing the amount of dietary protein below the recommended daily allowance of 0.8 g/kg/day is not recommended because it does not alter blood glucose levels, cardiovascular risk measures, or the course of GFR decline (46).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with CKD and diabetes, consuming protein below the recommended daily allowance of 0.8 g/kg/day is not recommended, because it does not alter blood glucose levels, cardiovascular risk measures, or the course of GFR decline (48).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Under those conditions, the development of malnutrition during a low-protein diet is an extremely rare event.115”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,974
Anthropometric standards for the assessment of growth and nutritional status
(1991) · Clinical Nutrition · doi:10.1016/0261-5614(91)90103-j · Cited by 1,197
The modification of diet in renal disease study group
Beck, G. J., Berg, R. L., Coggins, C. H., Gassman, J., Hunsicker, L. G., SCHLUCHTER, M. D., & Williams, G. W. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90069-x · Cited by 818
Self-citationA method for estimating nitrogen intake of patients with chronic renal failure
Maroni, B. J., Steinman, T. I., & Mitch, W. E. (1985) · Kidney International · doi:10.1038/ki.1985.10 · Cited by 789
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease
Brenner, P. D. B. M. (1983) · Kidney International · doi:10.1038/ki.1983.72 · Cited by 617
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J. B., ter Wee, P. M., Truus, S. M., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 554
The Modification of Diet in Renal Disease Study
Klahr, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201310 · Cited by 454
Self-citation
Research works printed but not linked: 6
- Hunsicker LG, 1989, Semin Nephrol, 9, 380
- 10.1001/archinte.153.2.154 · DOI
- Levey AS, 1989, Kidney Int Suppl, 27, S
- Kopple JD, 1989, Kidney Int Suppl, 27, S
- Greene T, 1993, J Am Soc Nephrol, 3, 1819
- 10.2307/2281868 · DOI · Paper page
Cited by
Sorted by citations
Items 701–800 of 1,000
The Nephrotic Syndrome is an immunoinflammatory disorder
Camici, M. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.072 · Cited by 41
ELLIS, D., MORITZ, M., Vats, A., & JANOSKY, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.014 · Cited by 41
Izzo, J. L., Neutel, J. M., Silfani, T. N., Dubiel, R., Walker, F., & on behalf of the Study Investigators (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175x.2007.5713.x · Cited by 41
Trends in the incidence of treated end-stage renal failure in The Netherlands: Hope for the future?
Gansevoort, R. T., Heij, B. V. D., Stegeman, C. A., de Charro, F., Nieuwenhuizen, M., de Zeeuw, D., & de Jong, P. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09202.x · Cited by 41
The Renal Tubule in the Progression of Chronic Renal Failure
Palmer, B. F. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500608 · Cited by 41
Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy
Huang, Z., Mou, Y., Xu, X., Zhao, D., Lai, Y., Xu, Y., Chen, C., Li, P., Peng, S., Tian, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00971 · Cited by 40
Lee, H., & Park, J. B. (2015) · Pulse · doi:10.1159/000381994 · Cited by 40
Tseng, C., Lafrance, J., Lu, S., Soroka, O., Miller, D. R., Maney, M., & POGACH, L. M. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0025-5 · Cited by 40
Kidney disease in the elderly: update on recent literature
Campbell, K. H., & O'Hare, A. (2008) · Current opinion in nephrology and hypertension · doi:10.1097/mnh.0b013e3282f5dd90 · Cited by 48
Liu, X., & Dai, C. (2016) · Kidney Diseases · doi:10.1159/000449029 · Cited by 39
Blood pressure and age-related GFR decline in the general population
Eriksen, B. O., Stefansson, V. T. N., Jenssen, T. G., Mathisen, U. D., Schei, J., Solbu, M. D., Wilsgaard, T., & Melsom, T. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0496-7 · Cited by 41
BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols
Drawz, P. E., & Ix, J. H. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070753 · Cited by 39
Kalim, S., Berg, A. H., Karumanchi, S. A., Thadhani, R., Allegretti, A. S., Nigwekar, S. U., Zhao, S. J., Srivastava, A., Raj, D. S., Deo, R., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa347 · Cited by 40
LIM, V. S., & Flanigan, M. J. (2001) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2001.00041.x · Cited by 40
McIntyre, N. J., & Taal, M. W. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328313675c · Cited by 38
Pentoxifylline: A potential therapy for chronic kidney disease
Lin, S., Chen, Y., Chiang, W., Tsai, T., & Wy, C. (2004) · Nephrology · doi:10.1111/j.1440-1797.2004.00267.x · Cited by 40
The renal consequences of arterial hypertension
Mountokalakis, T. D. (1997) · Kidney International · doi:10.1038/ki.1997.226 · Cited by 40
Tonelli, M. A. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.8.1426 · Cited by 39
Chang, T. I., Li, S., Chen, S., Peralta, C. A., Shlipak, M. G., Fried, L. F., Whaley‐Connell, A. T., McCullough, P. A., & Tamura, M. K. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.12.016 · Cited by 39
Shin, J., Park, J. B., Kim, K., Kim, J. H., Yang, D. H., Pyun, W. B., Kim, Y. G., Kim, G., & Chae, S. C. (2015) · Clinical Hypertension · doi:10.1186/s40885-014-0013-2 · Cited by 40
Kaze, F. F., Kengne, A. P., Magatsing, C. T., Halle, M., Mfopou, E. Y., & Ngu, K. B. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12781 · Cited by 39
Sternlicht, H., & Bakris, G. L. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.001 · Cited by 40
Ideal Target Blood Pressure in Hypertension
Park, S. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2019.0261 · Cited by 44
Neild, G. H. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-1107-4 · Cited by 39
Kobayashi, M., Hirawa, N., Morita, S., Yatsu, K., Kobayashi, Y., Yamamoto, Y., Saka, S., Toya, Y., Yasuda, G., & Umemura, S. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.018 · Cited by 39
Treatment of Microalbuminuria in Patients with Type 2 Diabetes Mellitus
Jerums, G., & MacIsaac, R. J. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201030-00004 · Cited by 39
IgA-Antigliadin Antibodies in Patients with IgA Nephropathy: The Secondary Phenomenon?
Ots, M., Uibo, O., Metsküla, K., Uibo, R., & Salupere, V. (1999) · American Journal of Nephrology · doi:10.1159/000013497 · Cited by 39
Abdelhafiz, A. H., Myint, M. P., Tayek, J. A., & Wheeldon, N. M. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.07.015 · Cited by 39
Educational Paper: Progression in chronic kidney disease and prevention strategies
Schaefer, B., & Wühl, E. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1814-5 · Cited by 39
Long-Term Knowledge Retention following Predialysis Psychoeducational Intervention
Devins, G. M., Hollomby, D. J., Barré, P. E., Mandin, H., Taub, K. J., Paul, L. C., Guttmann, R. D., & Binik, Y. M. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045730 · Cited by 39
Systolic Blood Pressure and Mortality Among Older Community-Dwelling Adults With CKD
Weiss, J. W., Johnson, E. S., Petrik, A. F., Smith, D. H., Yang, X., & Thorp, M. L. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.07.018 · Cited by 39
Zhang, Z., Shahinfar, S., Keane, W. F., Ramjit, D. R., Dickson, T. Z., Gleim, G. W., Mogensen, C. E., de Zeeuw, D., Brenner, B. M., & Snapinn, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080632 · Cited by 39
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression
Sarnak, M. J., Wang, S.-R., Beck, G. J., Kusek, J. W., Selhub, J., Greene, T., & Levey, A. S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36323 · Cited by 39
Self-citationRole of dietary protein and blood pressure in the progression of renal disease
Klahr, S. (1996) · Kidney International · doi:10.1038/ki.1996.267 · Cited by 39
Self-citationNEPHROPATHY AND HYPERTENSION IN DIABETES
Marks, J. B., & Raskin, P. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70028-6 · Cited by 37
Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented?
Davis, I. D., Dell, K. M., Sweeney, W. E., & Avner, E. D. (2001) · Seminars in Nephrology · doi:10.1053/snep.2001.24937 · Cited by 39
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.72 · Cited by 39
Resistant Hypertension and Associated Comorbidities in a Veterans Affairs Population
Acharya, T., Tringali, S., Singh, M., & Huang, J. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12410 · Cited by 38
Daly, C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm445 · Cited by 38
Dietary protein intake and change in estimated GFR in the Cardiovascular Health Study
Beasley, J. M., Katz, R., Shlipak, M. G., Rifkin, D. E., Siscovick, D. S., & Kaplan, R. C. (2013) · Nutrition · doi:10.1016/j.nut.2013.12.006 · Cited by 38
Vaes, B., Beke, E., Truyers, C., Elli, S., Buntinx, F., Verbakel, J. Y. J., Goderis, G., & Pottelbergh, G. V. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007571 · Cited by 38
Ishwaran, H., & Takahara, G. K. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502388618951 · Cited by 38
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins
Menon, V., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Selhub, J., Levey, A. S., & Sarnak, M. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00234.x · Cited by 38
Self-citationPrevention of Progression of Kidney Disease
Harris, D. A., Thomas, M. C., Johnson, D. W., Nicholls, K., & Gillin, A. G. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00505.x · Cited by 38
Reisin, E., Harris, R. C., & Rahman, M. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040371 · Cited by 38
Kutlugün, A. A., Arıcı, M., Yıldırım, T., Turgut, D., Yılmaz, R., Altındal, M., Altun, B., Erdem, Y., Yasavul, Ü., & Turgan, Ç. (2011) · Nephron Clinical Practice · doi:10.1159/000323392 · Cited by 37
Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes
Pena, M. J., de Zeeuw, D., Mischak, H., Jankowski, J., Oberbauer, R. W., Woloszczuk, W., Benner, J., Dallmann, G., Mayer, B., Mayer, G. J., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv252 · Cited by 39
Hsu, R. K., Chai, B., Roy, J. A., Anderson, A. H., Bansal, N., Feldman, H. I., Go, A. S., He, J., Horwitz, E. J., Kusek, J. W., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.025 · Cited by 37
Self-citationNutrition Interventions in Chronic Kidney Disease
Anderson, C. A. M., Nguyen, H. A., & Rifkin, D. E. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.06.008 · Cited by 37
Injured Podocytes Are Sensitized to Angiotensin II–Induced Calcium Signaling
Binz-Lotter, J., Jüngst, C., Rinschen, M. M., Koehler, S., Zentis, P., Schauss, A. C., Schermer, B., Benzing, T. R., & Hackl, M. J. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020109 · Cited by 37
Goraya, N., Maldonado, Y. M., Simoni, J., & Wesson, D. E. (2020) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2020.08.001 · Cited by 37
Ko, G.-J., & Kalantar‐Zadeh, K. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.197 · Cited by 44
Proteinuria and Microalbuminuria in Adults: Significance, Evaluation, and Treatment
Venkat, K. K. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000140833.51533.46 · Cited by 37
Sridhar, N. R., & Josyula, S. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-242 · Cited by 37
Salt: Its Role in Chronic Kidney Disease
Thijssen, S., Kitzler, T. M., & Levin, N. W. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.10.006 · Cited by 37
Diabetic nephropathy in African-American patients
Crook, E. D., & Patel, S. R. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0056-y · Cited by 37
Management of Early Diabetic Nephropathy
Molitch, M. E. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00118-6 · Cited by 37
Is all chronic kidney disease created equal?
Lane, B. R., Demirjian, S. G., Derweesh, I., Riedinger, C. B., Fergany, A. F., & Campbell, S. C. (2014) · Current Opinion in Urology · doi:10.1097/mou.0000000000000029 · Cited by 36
Renal protection in diabetes: lessons from ONTARGET®
Ritz, E., Schmieder, R. E., & Pollock, C. A. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-60 · Cited by 36
López, L. V., Acosta, M., Robles, M. V. G., Tamayo, M. T., & Limones, R. C. (2008) · PubMed · Cited by 36
A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
Vecchio, L. D., Beretta, A., Jovane, C., Peiti, S., & Genovesi, S. (2021) · Drugs · doi:10.1007/s40265-021-01573-3 · Cited by 37
Plant-Based versus Animal-Based Low Protein Diets in the Management of Chronic Kidney Disease
Mocanu, C.-A., Simionescu, T. P., Mocanu, A. E., & Gârneaţă, L. (2021) · Nutrients · doi:10.3390/nu13113721 · Cited by 42
Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy
Joss, N., Ferguson, C., Brown, C., Deighan, C. J., Paterson, K., & Boulton‐Jones, J. M. (2004) · QJM · doi:10.1093/qjmed/hch039 · Cited by 36
Chronic kidney disease: evolving strategies for detection and management of impaired renal function
MacGregor, M. S. (2006) · QJM · doi:10.1093/qjmed/hcl052 · Cited by 36
Soares, C. M., Diniz, J. S. S., de Lima, E. M., Oliveira, G. R., Canhestro, M. R., Colosimo, E. A., Silva, A. C. S. E., & OLIVEIRA, E. A. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn547 · Cited by 36
Hyperlipidaemia in Chronic Kidney Disease
Chan, C. (2005) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v34n1p31 · Cited by 36
Screening for renal insufficiency: is it worth while? is it feasible?
Jungers, P. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.9.2082 · Cited by 36
Nutrition Intervention Program of the Modification of Diet in Renal Disease Study
Gillis, B. P., Caggiula, A. W., CHIAVACCI, A. T., COYNE, T., DOROSHENKO, L., Milas, N. C., Nowalk, M. P., & SCHERCH, L. K. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00338-x · Cited by 36
Self-citationExploring Heterogeneity in Randomized Trials Via Meta-Analysis
Schmid, C. H. (1999) · Drug Information Journal · doi:10.1177/009286159903300124 · Cited by 36
Low-Protein Diet or Nutritional Therapy in Chronic Kidney Disease?
Bellizzi, V. (2013) · Blood Purification · doi:10.1159/000350585 · Cited by 35
Low-protein diet in chronic kidney disease: from questions of effectiveness to those of feasibility
Thilly, N. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft235 · Cited by 35
Physiological and Molecular Mechanisms of Methionine Restriction
Latimer, M. N., Freij, K. W., Cleveland, B. M., & Biga, P. R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00217 · Cited by 35
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Kramer, H., Townsend, R. R., Griffin, K. A., Flynn, J. T., Weiner, D. E., Rocco, M. V., Choi, M. J., Weir, M. R., Chang, T. I., Agarwal, R., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.01.007 · Cited by 37
Weldegiorgis, M., Smith, M. C., Herrington, W. G., Bankhead, C. R., & Woodward, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz059 · Cited by 36
Kalantar‐Zadeh, K., Rhee, C. M., Joshi, S., Brown-Tortorici, A., & Kramer, H. M. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000761 · Cited by 38
Giordano, M., Ciarambino, T., Castellino, P., Cataliotti, A., Malatino, L., Ferrara, N., Politi, C., & Paolisso, G. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.007 · Cited by 35
Performance Measurement in Chronic Kidney Disease
Smith, K. A., & Hayward, R. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111152 · Cited by 35
Fetuin-A is not associated with mortality in chronic kidney disease
Ix, J. H., Shlipak, M. G., Sarnak, M. J., Beck, G. J., Greene, T., Wang, X., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2007) · Kidney International · doi:10.1038/sj.ki.5002549 · Cited by 35
Self-citationStrategies to Retard the Progression of Chronic Kidney Disease
Zandi‐Nejad, K., & Brenner, B. M. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.11.001 · Cited by 35
PATHOLOGIC CLASSIFICATION OF CHRONIC ALLOGRAFT NEPHROPATHY: PATHOGENIC AND PROGNOSTIC IMPLICATIONS1
Cosío, B. G., Pelletier, R. P., Sedmak, D. D., Falkenhain, M. E., Henry, M. L., ELKHAMMAS, E. A., Davies, E. A., Bumgardner, G. L., & Ferguson, R. M. (1999) · Transplantation · doi:10.1097/00007890-199903150-00008 · Cited by 35
Registered Dietitian Time Requirements in the Modification of Diet in Renal Disease Study
Dolecek, T. A., Olson, M. B., Caggiula, A. W., Dwyer, J. T., Milas, N. C., Gillis, B. P., Hartman, J. A., & Dichiro, J. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00342-8 · Cited by 35
Self-citationComposite renal endpoints: was ACCOMPLISH accomplished?
Heerspink, H. L., & de Zeeuw, D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60098-0 · Cited by 39
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
Neuen, B. L., Tighiouart, H., Heerspink, H. J. L., Vonesh, E. F., Chaudhari, J., Miao, S., Chan, T. M., Fervenza, F. C., Floege, J., Goicoechea, M., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021070948 · Cited by 36
Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?
Theodorakopoulou, M. P., Ortíz, A., Fernández‐Fernández, B., Kanbay, M., Minutolo, R., & Sarafidis, P. A. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae278 · Cited by 46
Hypertension and Chronic Kidney Disease Progression: Why the Suboptimal Outcomes?
BIDANI, A. K., Griffin, K. A., & Epstein, M. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.04.008 · Cited by 34
Ruzicka, M., Quinn, R. R., McFarlane, P., Hemmelgarn, B. R., Prasad, G. V. R., Feber, J., NESRALLAH, G. E., MacKinnon, M., Tangri, N., McCormick, B. B., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.03.003 · Cited by 36
Gaggl, M., Cejka, D., Plischke, M., Heinze, G., Fraunschiel, M., Schmidt, A., Hörl, W. H., & Sunder–Plassmann, G. (2013) · Trials · doi:10.1186/1745-6215-14-196 · Cited by 33
Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?
Underwood, C. F., Hildreth, C. M., Wyse, B. F., Boyd, R. A., Goodchild, A. K., & Phillips, J. K. (2016) · Acta Physiologica · doi:10.1111/apha.12727 · Cited by 34
Major adverse renal events (MARE): a proposal to unify renal endpoints
Prischl, F. C., Rossing, P. R., Bakris, G. L., Mayer, G. J., & Wanner, C. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz212 · Cited by 35
Park, S., Lee, S., Kim, Y., Lee, Y., Kang, M. W., Kim, K., Kim, Y. C., Han, S. S., Lee, H., Lee, J. P., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa379 · Cited by 33
Dietary management of chronic kidney disease
Goraya, N., & Wesson, D. E. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328357a69b · Cited by 34
Nutrition in patients with Type 2 diabetes: are low‐carbohydrate diets effective, safe or desirable?
Kennedy, R. L., Chokkalingam, K., & Farshchi, H. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01594.x · Cited by 35
Usami, T., Nakao, N., Fukuda, M., Takeuchi, O., Kamiya, Y., Yoshida, A., & Kimura, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00221.x · Cited by 34
Ferrari, P. (2007) · Nephrology · doi:10.1111/j.1440-1797.2006.00749.x · Cited by 34
How to Manage Elderly Patients with Chronic Renal Failure: Conservative Management versus Dialysis
Brunori, G., Viola, B. F., Maiorca, P., & Cancarini, G. C. (2008) · Blood Purification · doi:10.1159/000110561 · Cited by 34
Fortnightly Review: Glomerulonephritis: diagnosis and treatment
Mason, P. D., & Pusey, C. D. (1994) · BMJ · doi:10.1136/bmj.309.6968.1557 · Cited by 34
Hirano, K., Kawamura, T., Tsuboi, N., Okonogi, H., Miyazaki, Y., Ikeda, M., Matsushima, M., Hanaoka, K., Ogura, M., Utsunomiya, Y., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0744-x · Cited by 33
Evans, L. C., Ryan, R. P., Broadway, E., Skelton, M. M., Kurth, T. M., & Cowley, A. W. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04468 · Cited by 33
Dietary Care for ADPKD Patients: Current Status and Future Directions
Carriazo, S. M., Pérez-Gómez, M. V., Cordido, A., García-González, M. Á., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2019) · Nutrients · doi:10.3390/nu11071576 · Cited by 34
Hypertension Management in Patients with Chronic Kidney Disease
Hebert, S. A., & Ibrahim, H. N. (2022) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1119 · Cited by 43
Metadata
- Authors
- Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G.
- Affiliations
- National Institutes of Health (US)
- Tufts Medical Center (US)
- Cleveland Clinic (US)
- University of Pittsburgh (US)
- University of Iowa Hospitals and Clinics (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1994-03-31
- Volume
- 330
- Issue
- 13
- Pages
- 877-884
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2321986725
- Semantic Scholar
- 01e2c22d0073b85c7e2ba3a9327f2c898329d6af
- Cited by
- 2,328
- References
- 30
- Citations by year
- 2026: 25 · 2025: 53 · 2024: 56 · 2023: 66 · 2022: 64 · 2021: 74 · 2020: 73 · 2019: 82 · 2018: 81 · 2017: 98 · 2016: 82 · 2015: 84 · 2014: 100 · 2013: 92 · 2012: 92
- FWCI
- 51.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, protein restriction, very low protein diet, low-protein diet, blood pressure control, hypertension, glomerular filtration rate decline, end-stage renal disease, proteinuria, renal failure, disease progression, mortality, renal function decline, end-stage renal disease prevention, mortality prevention
- MeSH terms
- Blood Pressure, Chronic Disease, Dietary Proteins, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Hypertension, Kidney Diseases, Kidney Failure, Chronic, Polycystic Kidney Diseases, Male, Middle Aged, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
